<!DOCTYPE html>
<html lang="en" data-theme="light">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Skin and Eye Disorders - Pharmacology and Pharmacotherapeutics</title>
    
    <link rel="preconnect" href="https://fonts.googleapis.com">
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700&family=Source+Serif+4:opsz,wght@8..60,400;8..60,600&display=swap" rel="stylesheet">
    
    <link rel="stylesheet" href="../styles/main.css">
    
    <script>
    MathJax = {
        tex: {
            inlineMath: [['$', '$'], ['\\(', '\\)']],
            displayMath: [['$$', '$$'], ['\\[', '\\]']],
            processEscapes: true,
            processEnvironments: true,
            tags: 'ams'
        },
        svg: { fontCache: 'global' },
        options: {
            skipHtmlTags: ['script', 'noscript', 'style', 'textarea', 'pre']
        }
    };
    </script>
    <script id="MathJax-script" async src="https://cdn.jsdelivr.net/npm/mathjax@3/es5/tex-mml-chtml.js"></script>
</head>
<body>
    <a href="#main-content" class="skip-link">Skip to main content</a>
    
    <div class="reading-progress-container">
        <div class="reading-progress-bar" id="reading-progress"></div>
    </div>

    <button class="theme-toggle" id="theme-toggle" aria-label="Toggle dark mode">
        <span class="theme-toggle-icon light-icon">‚òÄÔ∏è</span>
        <span class="theme-toggle-icon dark-icon">üåô</span>
    </button>

    <!-- Floating Table of Contents -->
    <div class="floating-toc" id="floating-toc">
        <div class="floating-toc-header">
            <span>üìë</span>
            <span>Contents</span>
        </div>
        <ul class="floating-toc-list">
            <!-- JS will populate this -->
        </ul>
    </div>

    <div class="page-wrapper">
        <div class="container">
            <article class="document-article">
                <header class="document-header">
                    <div class="header-badge">
                        <span>üëÅÔ∏è</span>
                        <span>Section XIV</span>
                    </div>
                    <h1 class="document-title">Drugs Used in Common Skin and Eye Disorders</h1>
                    <div class="title-meta">
                        <div class="meta-item">
                            <span>üìö</span>
                            <span>Dermatology & Ophthalmology</span>
                        </div>
                        <div class="meta-item">
                            <span>‚è±Ô∏è</span>
                            <span>60 min read</span>
                        </div>
                    </div>
                </header>

                <main id="main-content" class="content-wrapper">
                    <!-- START: Chapter 71 -->
                    <section class="content-section" id="chapter-71">
                        <div class="section-header">
                            <div class="section-number">71</div>
                            <h2 class="section-title">
                                <span class="title-icon">üß¥</span>
                                Pharmacotherapy of Common Skin Disorders
                            </h2>
                        </div>

                        <div class="content-card">
                            <h3>Principles of Drug Application</h3>
                            <p>Skin diseases are common in clinical practice. The skin forms a barrier between the organism and its external environment. The absorption of drugs into the skin is slow and incomplete. It depends on:</p>
                            <ul>
                                <li>The lipid solubility of the preparation.</li>
                                <li>The state of hydration of the stratum corneum - Increased hydration increases the drug penetration.</li>
                                <li>Drug concentration in the vehicle.</li>
                                <li>Thickness of the skin (the thicker the skin the lower the drug penetration).</li>
                                <li>Quantity of the preparation applied.</li>
                                <li>The presence of inflamed skin which allows higher penetration of a drug.</li>
                                <li>The use of an occlusive dressing which increases the drug penetration into the skin.</li>
                            </ul>

                            <h3>Vehicles and Formulations</h3>
                            <p>Topical preparations consist of two parts: (1) the base or vehicle and (2) the active ingredient(s).</p>
                            <div class="table-responsive">
                                <table class="comparison-table">
                                    <thead>
                                        <tr>
                                            <th>Vehicle Type</th>
                                            <th>Characteristics & Uses</th>
                                        </tr>
                                    </thead>
                                    <tbody>
                                        <tr>
                                            <td><strong>Powders</strong></td>
                                            <td>Absorb moisture, reduce friction, cooling effect. (Talc, starch, zinc stearate).</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Lotions</strong></td>
                                            <td>Liquid preparations. Cooling effect via evaporation. Used for subacute inflammation.</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Wet Dressings</strong></td>
                                            <td>For acute exudative inflammation with marked oozing. (Potassium permanganate 0.01-0.05%).</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Creams/Ointments</strong></td>
                                            <td>Lubricating (Emollients). Soothe and hydrate dry/scaling disorders. Ointments are more hydrating than creams.</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Pastes</strong></td>
                                            <td>Stiffer, adhesive. Protect skin from external irritants and sunlight.</td>
                                        </tr>
                                    </tbody>
                                </table>
                            </div>

                            <h3>Drug Therapy of Skin Infections</h3>

                            <h4>1. Bacterial Infections</h4>
                            <p><strong>Impetigo:</strong> Superficial infection (Staph/Strep). Treatment: Cleaning/debridement + Topical antibiotics (Mupirocin 2%, Framycetin, Bacitracin). Systemic antibiotics (Cloxacillin, Erythromycin) indicated if risk of glomerulonephritis or severe infection.</p>
                            <p><strong>Furuncle (Boil):</strong> Staphylococcal infection of hair follicle. Treatment: Local antiseptics, fomentation. Systemic antibiotics in severe cases.</p>

                            <h4>2. Viral Infections</h4>
                            <p><strong>Herpes Simplex:</strong> Topical Acyclovir 5% (less effective than systemic).
                            <br><strong>Herpes Zoster:</strong> Oral Acyclovir (800 mg 5 times/day). Post-herpetic neuralgia treated with topical Capsaicin, analgesics, or amitriptyline.
                            <br><strong>Warts:</strong> Salicylic acid, Podophyllin (15-25%), Trichloracetic acid, Cryotherapy.</p>

                            <h4>3. Fungal Infections</h4>
                            <p><strong>Superficial Mycoses (Ringworm, Candidiasis, Tinea Versicolor):</strong>
                            <br><strong>Topical Azoles:</strong> Clotrimazole, Miconazole, Ketoconazole, Econazole.
                            <br><strong>Whitfield's Ointment:</strong> Benzoic acid (6%) + Salicylic acid (3%). Cheap and effective.
                            <br><strong>Tolnaftate, Terbinafine (1%):</strong> Effective for dermatophytosis.
                            <br><strong>Systemic Therapy:</strong> Griseofulvin, Fluconazole, Itraconazole (for onychomycosis/extensive lesions).</p>

                            <h4>4. Scabies and Pediculosis</h4>
                            <div class="grid grid-2">
                                <div class="grid-item">
                                    <h4>Scabies (Sarcoptes scabiei)</h4>
                                    <ul>
                                        <li><strong>Permethrin (5%):</strong> Drug of choice. Applied to whole body, left for 8-12 hours.</li>
                                        <li><strong>Benzyl Benzoate (25%):</strong> Emulsion. Effective but irritant.</li>
                                        <li><strong>Gamma Benzene Hexachloride (Lindane 1%):</strong> Neurotoxic potential. Avoid in children.</li>
                                        <li><strong>Ivermectin:</strong> Oral (200 mcg/kg). Single dose, repeat after 2 weeks.</li>
                                    </ul>
                                </div>
                                <div class="grid-item">
                                    <h4>Pediculosis (Lice)</h4>
                                    <ul>
                                        <li><strong>Permethrin (1%):</strong> Cream/Lotion. Drug of choice.</li>
                                        <li><strong>Malathion (0.5%):</strong> Ovicidal. Inflammable.</li>
                                        <li><strong>Ivermectin:</strong> Oral.</li>
                                        <li><strong>DDT/Gamma BHC:</strong> Resistance common.</li>
                                    </ul>
                                </div>
                            </div>

                            <h3>Acne Vulgaris</h3>
                            <p>Pathophysiology involves increased sebum, hyperkeratinisation (comedones), and <em>Propionibacterium acnes</em> proliferation.</p>
                            
                            <div class="table-responsive">
                                <table class="comparison-table">
                                    <thead>
                                        <tr>
                                            <th>Class</th>
                                            <th>Drugs</th>
                                            <th>Mechanism/Use</th>
                                        </tr>
                                    </thead>
                                    <tbody>
                                        <tr>
                                            <td><strong>Comedolytics</strong></td>
                                            <td><strong>Tretinoin</strong> (Retinoic acid), Adapalene</td>
                                            <td>Normalise keratinisation. Apply topically. Avoid sun exposure. Contraindicated in pregnancy.</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Keratolytics</strong></td>
                                            <td>Benzoyl Peroxide, Salicylic acid</td>
                                            <td>Peeling agents. Benzoyl peroxide is also antibacterial against <em>P. acnes</em>.</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Antibiotics</strong></td>
                                            <td>Topical: Clindamycin, Erythromycin<br>Systemic: Doxycycline, Minocycline</td>
                                            <td>Inhibit <em>P. acnes</em> and inflammation.</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Sebostatics</strong></td>
                                            <td><strong>Isotretinoin</strong> (Oral)</td>
                                            <td>For severe cystic acne. Inhibits sebum. <strong>Highly Teratogenic</strong>.</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Hormonal</strong></td>
                                            <td>Estrogens, Cyproterone acetate</td>
                                            <td>Anti-androgenic action (in females).</td>
                                        </tr>
                                    </tbody>
                                </table>
                            </div>

                            <h3>Psoriasis</h3>
                            <p>Chronic inflammatory dermatosis with plaques and scaling.</p>
                            
                            <h4>Topical Therapy</h4>
                            <ul>
                                <li><strong>Emollients:</strong> Hydrate and soften scales.</li>
                                <li><strong>Keratolytics:</strong> Salicylic acid (2-10%).</li>
                                <li><strong>Coal Tar / Dithranol:</strong> Cytostatic. Stain skin/clothes.</li>
                                <li><strong>Glucocorticoids:</strong> Topical. Rapid relief but relapse common.</li>
                                <li><strong>Calcipotriol:</strong> Vitamin D analogue. Inhibits proliferation. Safe and effective.</li>
                                <li><strong>Tazarotene:</strong> Topical retinoid.</li>
                            </ul>

                            <h4>Systemic Therapy (Severe Cases)</h4>
                            <ul>
                                <li><strong>Phototherapy:</strong> PUVA (Psoralen + UVA) or UVB.</li>
                                <li><strong>Methotrexate:</strong> Folic acid antagonist. Cytostatic/Immunosuppressant.</li>
                                <li><strong>Acitretin:</strong> Oral retinoid. Teratogenic (avoid pregnancy for 3 years after stopping).</li>
                                <li><strong>Cyclosporine:</strong> Immunosuppressant.</li>
                                <li><strong>Biologicals:</strong> Etanercept, Infliximab, Adalimumab (TNF-$\alpha$ inhibitors), Ustekinumab (IL-12/23 blocker). Expensive.</li>
                            </ul>
                        </div>
                    </section>
                    <!-- END: Chapter 71 -->

                    <!-- START: Chapter 72 -->
                    <section class="content-section" id="chapter-72">
                        <div class="section-header">
                            <div class="section-number">72</div>
                            <h2 class="section-title">
                                <span class="title-icon">üëÅÔ∏è</span>
                                Ocular Pharmacology
                            </h2>
                        </div>

                        <div class="content-card">
                            <h3>Pharmacokinetics of Ocular Drugs</h3>
                            <p>Most drugs are administered topically (drops/ointments). Only ~1% penetrates the cornea. Absorption depends on lipid solubility (epithelium is lipophilic, stroma is hydrophilic). Ointments increase contact time. Systemic absorption can occur via nasolacrimal duct.</p>

                            <h3>Antimicrobial Agents</h3>
                            <div class="table-responsive">
                                <table class="comparison-table">
                                    <thead>
                                        <tr>
                                            <th>Class</th>
                                            <th>Drugs</th>
                                            <th>Indications</th>
                                        </tr>
                                    </thead>
                                    <tbody>
                                        <tr>
                                            <td><strong>Antibacterial</strong></td>
                                            <td>Sulfacetamide (10-30%), Chloramphenicol, Gentamicin, Tobramycin, Ciprofloxacin, Ofloxacin, Moxifloxacin.</td>
                                            <td>Conjunctivitis, Corneal ulcers, Blepharitis.</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Antiviral</strong></td>
                                            <td>Acyclovir (3% ointment), Trifluridine, Ganciclovir.</td>
                                            <td>Herpes simplex keratitis.</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Antifungal</strong></td>
                                            <td>Natamycin (5%), Amphotericin B, Fluconazole.</td>
                                            <td>Fungal keratitis.</td>
                                        </tr>
                                    </tbody>
                                </table>
                            </div>

                            <h3>Anti-inflammatory Agents</h3>
                            <ul>
                                <li><strong>NSAIDs:</strong> Flurbiprofen, Diclofenac, Ketorolac drops. Used to prevent intraoperative miosis and for allergic conjunctivitis.</li>
                                <li><strong>Glucocorticoids:</strong> Dexamethasone, Betamethasone, Prednisolone. Used for Uveitis, allergic conditions, post-op inflammation. <strong>Hazards:</strong> Glaucoma (steroid-induced), Cataract, superinfection (fungal/viral). <strong>Contraindicated</strong> in dendritic ulcer (Herpes simplex).</li>
                            </ul>

                            <h3>Mydriatics and Miotics</h3>
                            <div class="grid grid-2">
                                <div class="grid-item">
                                    <h4>Mydriatics (Dilate Pupil)</h4>
                                    <ul>
                                        <li><strong>Antimuscarinics:</strong> Atropine (Long acting, 7-10 days cycloplegia), Homatropine, Cyclopentolate, Tropicamide (Shortest acting, for refraction).</li>
                                        <li><strong>Sympathomimetics:</strong> Phenylephrine (No cycloplegia).</li>
                                    </ul>
                                </div>
                                <div class="grid-item">
                                    <h4>Miotics (Constrict Pupil)</h4>
                                    <ul>
                                        <li><strong>Cholinomimetics:</strong> Pilocarpine.</li>
                                        <li><strong>Anticholinesterases:</strong> Physostigmine, Echothiophate (rarely used).</li>
                                    </ul>
                                </div>
                            </div>

                            <h3>Drug Therapy of Glaucoma</h3>
                            <p>Goal is to lower Intraocular Pressure (IOP) by increasing outflow or decreasing production of aqueous humor.</p>
                            
                            <div class="table-responsive">
                                <table class="comparison-table">
                                    <thead>
                                        <tr>
                                            <th>Class</th>
                                            <th>Drugs</th>
                                            <th>Mechanism</th>
                                        </tr>
                                    </thead>
                                    <tbody>
                                        <tr>
                                            <td><strong>Prostaglandin Analogues</strong></td>
                                            <td>Latanoprost, Bimatoprost, Travoprost</td>
                                            <td>Increase uveoscleral outflow. <strong>First line drugs</strong> (Once daily). ADR: Iris pigmentation, eyelash growth.</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Beta Blockers</strong></td>
                                            <td>Timolol, Betaxolol ($\beta_1$ selective)</td>
                                            <td>Decrease aqueous production.</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Alpha-2 Agonists</strong></td>
                                            <td>Brimonidine, Apraclonidine</td>
                                            <td>Decrease production + Increase uveoscleral outflow.</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Carbonic Anhydrase Inhibitors</strong></td>
                                            <td>Dorzolamide, Brinzolamide (Topical)<br>Acetazolamide (Systemic)</td>
                                            <td>Decrease aqueous production.</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Miotics (Cholinomimetics)</strong></td>
                                            <td>Pilocarpine</td>
                                            <td>Increase trabecular outflow (opens meshwork). Drug of choice for <strong>Acute Congestive Glaucoma</strong>.</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Osmotic Agents</strong></td>
                                            <td>Mannitol (IV), Glycerol (Oral)</td>
                                            <td>Rapidly lower IOP in acute attack by osmotic dehydration of vitreous.</td>
                                        </tr>
                                    </tbody>
                                </table>
                            </div>

                            <h3>Miscellaneous</h3>
                            <ul>
                                <li><strong>Local Anaesthetics:</strong> Proparacaine, Tetracaine, Lignocaine. For tonometry, foreign body removal, surgery.</li>
                                <li><strong>Diagnostic Dyes:</strong> Fluorescein (detects corneal abrasions/ulcers - stains green), Rose Bengal.</li>
                                <li><strong>Artificial Tears:</strong> Methylcellulose, Polyvinyl alcohol. For dry eyes (Keratoconjunctivitis sicca).</li>
                            </ul>
                            
                            <div class="callout callout--danger">
                                <div class="callout-header">
                                    <span class="callout-icon">‚ö†Ô∏è</span>
                                    <h4 class="callout-title">Drug Induced Ocular Toxicity</h4>
                                </div>
                                <div class="callout-content">
                                    <ul>
                                        <li><strong>Ethambutol:</strong> Optic neuritis, color blindness.</li>
                                        <li><strong>Chloroquine:</strong> Retinopathy (Bull's eye maculopathy).</li>
                                        <li><strong>Steroids:</strong> Cataract, Glaucoma.</li>
                                        <li><strong>Amiodarone:</strong> Corneal microdeposits.</li>
                                        <li><strong>Sildenafil:</strong> Blue vision (PDE-6 inhibition).</li>
                                    </ul>
                                </div>
                            </div>
                        </div>
                    </section>
                    <!-- END: Chapter 72 -->
                </main>

                <nav class="document-nav">
                    <div class="nav-container">
                        <a href="section-13b.html" class="nav-button nav-button--large nav-button--previous">
                            <div class="nav-label">Previous</div>
                            <div class="nav-title">Section XIII (Part B): Endocrine</div>
                        </a>
                        
                        <div class="document-progress">
                            <div class="progress-indicator">
                                <span>14</span>
                                <span class="progress-separator">/</span>
                                <span>16</span>
                            </div>
                        <a href="../index.html" class="nav-button nav-button--large">
                            <div class="nav-label">Go to</div>
                            <div class="nav-title">Index</div>
                        </a>
                            <div class="progress-bar-container">
                                <div class="progress-bar-fill" style="width: 87.5%;"></div>
                            </div>
                            <div class="progress-label">Section 14 of 16</div>
                        </div>
                        
                        <a href="section-15.html" class="nav-button nav-button--large nav-button--next">
                            <div class="nav-label">Next</div>
                            <div class="nav-title">Section XV: Immunopharmacology</div>
                        </a>
                    </div>
                </nav>
            </article>
        </div>
    </div>

    <!-- Lightbox Modal -->
    <div class="lightbox-modal" id="lightbox-modal" role="dialog" aria-modal="true" aria-label="Image viewer" hidden>
        <div class="lightbox-backdrop"></div>
        <div class="lightbox-content">
            <button class="lightbox-close" aria-label="Close image viewer">√ó</button>
            <img class="lightbox-image" src="" alt="">
            <p class="lightbox-caption"></p>
        </div>
    </div>

    <script src="../js/theme.js"></script>
    <script src="../js/navigation.js"></script>
    <script src="../js/interactions.js"></script>
</body>
</html>